In a revolutionary development, CRISPR gene editing emerged as a beacon of hope for people suffering from genetic blindness. The results of a Phase 1/2 clinical trial revealed promising results, sparking confidence in the medical world and providing a ray of hope to people suffering from vision Read More...
20 years ago, James O’Brien endured something horrible: a corrosive acid substance was thrown in his face, leaving him permanently blind in one eye. Or at least, so he thought. For the past 18 months, O’Brien has been undergoing pioneering treatment at London’s Moorfields Eye Hospital. Read More...